Healthcare Dec 31, 2021 02:06 PM (GMT+8) · EqualOcean
Recently, The human KRAS gene mutation detection kit (fluorescence PCR method) independently developed by Beijing yakangbo Biotechnology Co., Ltd. has passed the State Drug Administration (nmpa), the third class medical device registration certificate was officially approved. This kit is the first KRAS gene mutation detection kit with concomitant diagnosis function based on PCR platform in China. It can be used to detect 7 KRAS gene mutations in adult colorectal cancer patients in vitro and assist clinicians to judge the benefits of patients using cetuximab injection.

This text is a result of machine translation.